Literature DB >> 23929898

Relation of regional fat distribution to left ventricular structure and function.

Ian J Neeland1, Sachin Gupta, Colby R Ayers, Aslan T Turer, J Eduardo Rame, Sandeep R Das, Jarett D Berry, Amit Khera, Darren K McGuire, Gloria L Vega, Scott M Grundy, James A de Lemos, Mark H Drazner.   

Abstract

BACKGROUND: The relation of body fat distribution to left ventricular (LV) structure and function is poorly defined. METHODS AND
RESULTS: A total of 2710 participants without heart failure or LV dysfunction in the Dallas Heart Study underwent dual energy x-ray absorptiometry and MRI assessment of fat distribution, LV morphology, and hemodynamics. Cross-sectional associations of fat distribution with LV structure and function were examined after adjustment for age, sex, race, comorbidities, and lean mass. Mean age was 44 years with 55% women; 48% blacks; and 44% obese. After multivariable adjustment, visceral adipose tissue was associated with concentric remodeling characterized by lower LV end-diastolic volume (β=-0.21), higher concentricity (β=0.20), and wall thickness (β=0.09; P<0.0001 for all). In contrast, lower body subcutaneous fat was associated with higher LV end-diastolic volume (β=0.48), reduced concentricity (β=-0.50), and wall thickness (β=-0.28, P<0.0001 for all). Visceral adipose tissue was also associated with lower cardiac output (β=-0.10, P<0.05) and higher systemic vascular resistance (β=0.08, P<0.05), whereas lower body subcutaneous fat associated with higher cardiac output (β=0.20, P<0.0001) and lower systemic vascular resistance (β=-0.18, P<0.0001). Abdominal subcutaneous fat showed weaker associations with concentric remodeling and was not associated with hemodynamics. Among the subset of obese participants, visceral adipose tissue, but not abdominal subcutaneous fat, was significantly associated with concentric remodeling.
CONCLUSIONS: Visceral adipose tissue, a marker of central adiposity, was independently associated with concentric LV remodeling and adverse hemodynamics. In contrast, lower body subcutaneous fat was associated with eccentric remodeling. The impact of body fat distribution on heart failure risk requires prospective study.

Entities:  

Keywords:  body fat distribution; concentric remodeling; hypertrophy, left ventricular; intra-abdominal fat; obesity

Mesh:

Year:  2013        PMID: 23929898      PMCID: PMC3931513          DOI: 10.1161/CIRCIMAGING.113.000532

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  32 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction.

Authors:  Michael R Zile; John S Gottdiener; Scott J Hetzel; John J McMurray; Michel Komajda; Robert McKelvie; Catalin F Baicu; Barry M Massie; Peter E Carson
Journal:  Circulation       Date:  2011-11-07       Impact factor: 29.690

3.  Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice.

Authors:  N Abate; A Garg; R Coleman; S M Grundy; R M Peshock
Journal:  Am J Clin Nutr       Date:  1997-02       Impact factor: 7.045

4.  Human body surface area: measurement and prediction using three dimensional body scans.

Authors:  P Tikuisis; P Meunier; C E Jubenville
Journal:  Eur J Appl Physiol       Date:  2001-08       Impact factor: 3.078

5.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

6.  Effects of isolated obesity on systolic and diastolic left ventricular function.

Authors:  M Pascual; D A Pascual; F Soria; T Vicente; A M Hernández; F J Tébar; M Valdés
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

7.  Impact of blood pressure and insulin on the relationship between body fat and left ventricular structure.

Authors:  Kristjan Karason; Lars Sjöström; Ingemar Wallentin; Markku Peltonen
Journal:  Eur Heart J       Date:  2003-08       Impact factor: 29.983

8.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

Authors:  Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

9.  The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy.

Authors:  Lazaros A Nikolaidis; Anthony Sturzu; Carol Stolarski; Dariush Elahi; You-Tang Shen; Richard P Shannon
Journal:  Cardiovasc Res       Date:  2004-02-01       Impact factor: 10.787

10.  The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study.

Authors:  M S Lauer; K M Anderson; W B Kannel; D Levy
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

View more
  62 in total

1.  Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study.

Authors:  Yuichiro Yano; Wanpen Vongpatanasin; Colby Ayers; Aslan Turer; Alvin Chandra; Mercedes R Carnethon; Philip Greenland; James A de Lemos; Ian J Neeland
Journal:  Hypertension       Date:  2016-07-18       Impact factor: 10.190

2.  Factors Associated With Left Atrial Remodeling in the General Population.

Authors:  Walter Oliver; Gwendolyn Matthews; Colby R Ayers; Sonia Garg; Sachin Gupta; Ian J Neeland; Mark H Drazner; Jarett D Berry; Susan Matulevicius; James A de Lemos
Journal:  Circ Cardiovasc Imaging       Date:  2017-02       Impact factor: 7.792

3.  Is obesity predictive of cardiovascular dysfunction independent of cardiovascular risk factors?

Authors:  E DeVallance; S B Fournier; D A Donley; D E Bonner; K Lee; J C Frisbee; P D Chantler
Journal:  Int J Obes (Lond)       Date:  2014-06-24       Impact factor: 5.095

Review 4.  Regression of Left Ventricular Mass After Bariatric Surgery.

Authors:  Thierry H Le Jemtel; Rohan Samson; Abhishek Jaiswal; Eliza B Lewine; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-09       Impact factor: 5.369

5.  Visceral adiposity and left ventricular remodeling: The Multi-Ethnic Study of Atherosclerosis.

Authors:  S A Abbasi; W G Hundley; D A Bluemke; M Jerosch-Herold; R Blankstein; Steffen E Petersen; Oliver J Rider; J A C Lima; M A Allison; V L Murthy; R V Shah
Journal:  Nutr Metab Cardiovasc Dis       Date:  2015-04-16       Impact factor: 4.222

6.  Effect of plasma NOx values on cardiac function in obese hypertensive and normotensive pediatric patients.

Authors:  Meltem Akcaboy; Serdar Kula; Tayfun Göktas; Bijen Nazlıel; Semiha Terlemez; Nurullah Celik; Bülent Celik; Necla Buyan
Journal:  Pediatr Nephrol       Date:  2015-10-19       Impact factor: 3.714

Review 7.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

8.  Quantitative trait mapping in Diversity Outbred mice identifies two genomic regions associated with heart size.

Authors:  John R Shorter; Wei Huang; Ju Youn Beak; Kunjie Hua; Daniel M Gatti; Fernando Pardo-Manuel de Villena; Daniel Pomp; Brian C Jensen
Journal:  Mamm Genome       Date:  2017-12-26       Impact factor: 2.957

9.  Pericardial, But Not Hepatic, Fat by CT Is Associated With CV Outcomes and Structure: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Ravi V Shah; Amanda Anderson; Jingzhong Ding; Matthew Budoff; Oliver Rider; Steffen E Petersen; Majken Karoline Jensen; Manja Koch; Matthew Allison; Nadine Kawel-Boehm; Jessica Wisocky; Michael Jerosch-Herold; Kenneth Mukamal; João A C Lima; Venkatesh L Murthy
Journal:  JACC Cardiovasc Imaging       Date:  2017-03-15

Review 10.  Impact of empagliflozin in patients with diabetes and heart failure.

Authors:  David Pham; Natalia De Albuquerque Rocha; Darren K McGuire; Ian J Neeland
Journal:  Trends Cardiovasc Med       Date:  2016-08-04       Impact factor: 6.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.